Quality System Regulation (QSR) Management Responsibilities

Instructor: Daniel O Leary
Product ID: 701762
  • Duration: 75 Min
This (QSR) Quality System Regulation webinar describes management responsibility by reviewing the Quality System Regulation (QSR) and the reasoning that FDA published. It covers each of the components of management responsibility and provides a list of things you should consider in your implementation.

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Oct-2010

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367

Email: customercare@complianceonline.com

Read Frequently Asked Questions

Why Should You Attend:

One of the most common areas for FDA Warning Letters is Management Responsibility. FDA considers this a principal subsystem and is where they start inspections. Ensuring that you understand what they expect and how to implement it is a valuable approach to preventing problems.

This webinar examines the requirements for management responsibility using information provided by the FDA. We look at the structure of the regulation in 21 CFR §820.20 and its constituent parts. This section has many defined terms that bear on the understanding. The webinar looks at these terms and explains what they mean. For example, in your company, have you identified “management with executive responsibility”?.

QSR preamble - FDA published draft regulations for comment, and then addresses the comments they received. These comments can help you understand FDA’s intention and what they expect. FDA developed the Quality System Inspection Technique to guide its inspectors. The document has flow charts and narrative that the webinar includes as part of the analysis.

The webinar looks at some warning letters that represent problems the FDA found in management responsibility as they conducted their inspections.These warning letters will help you avoid the same problems.

For each of the topics, the webinar provides a list of things for you to consider. The lists suggest approaches to each component and give some guidance that will make your implementation more successful.

Areas Covered in the Seminar:

  • Valuable documents that provide understanding.
    • Quality System Regulation (QSR), including the definitions
    • QSR Preamble
    • FDA Paperwork Act submission for QSR (Quality System Regulation)
    • FDA’s Quality System Inspection Technique (QSIT) manual
    • Warning Letters
  • Subject Areas covered.
    • Quality policy
    • Organization
    • Responsibility and authority
    • Resources
    • Management Representative
    • Management review
    • Quality planning
    • Quality system procedures
  • For each subject area, the webinar includes information from the valuable documents listed above.

Related Technical Documents:

  • FDA QSR as published in 21 CFR Part 820
  • FDA QSR Preamble as published in 61 FR 52601-52662
  • QSR Paperwork Reduction Act Supporting Statement - OMB No. 0910-0073
  • Guide to Inspections of Quality Systems
  • FDA Warning Letters

Who Will Benefit:

This webinar provides information for people involved in medical devices regulated by the FDA. People in the following roles can especially benefit from the knowledge in this webinar:

  • Device company executives
  • Device company managers
  • Quality Managers
  • Regulatory Affairs Managers
  • Risk Managers
  • Management Representatives
  • Production Managers
  • Design Engineering Managers

Instructor Profile:

Daniel O'Leary, is the President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence, focused on analytic skills and a systems approach to operations management. Dan has more than 30 years experience in quality, operations, and program management in regulated industries including aviation, defense, medical devices, and clinical labs. He has a Masters Degree in Mathematics; is an ASQ certified Biomedical Auditor, Quality Auditor, Quality Engineer, Reliability Engineer, and Six Sigma Black Belt; and is certified by APICS in Resource Management.

Follow us :
Seminars by Ex-FDA Officials
Biocompatibility Testing for Medical Devices

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@complianceonline.com call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed